ELK1 is a convergence point for signaling pathways downstream of EGFR, including PI3K/Akt, and RNAi knockdown of ELK1 reduces the growth and survival of U138 glioblastoma cells [45]. This evidence concerns the gene AKT1 and glioblastoma.